After two years of treatment to get Afib under control, Thosani enrolled in the REACT-AF study, and says he has been off his ...

‘We are at a crossroads’: Prince Harry and Meghan Markle issue new video message Political Novice Levi Strauss Heir Defeats ...

Johnson & Johnson MedTech has received the US Food and Drug Administration (FDA) approval for its VARIPULSE Platform to treat ...

Boston Scientific is resuming its "Avant Guard" study of pulse field ablation (PFA) as a first-line therapy for atrial ...

Atrial fibrillation, or AFib is the most common type of heart arrhythmia. A new type of procedure is helping get hearts back on beat.

J&J is the third medtech company to gain U.S. approval for pulsed field ablation, a new atrial fibrillation treatment seeing ...

Fib, is a cardiac disorder involving the heart’s rate and rhythm. It is characterized by an irregular heartbeat rhythm ...

Boston Scientific ( NYSE: BSX) has agreed to acquire privately held medical technology company, Cortex, Inc.

Johnson & Johnson MedTech announced today that the FDA approved its Varipulse pulsed field ablation (PFA) platform for ...

Irvine: Johnson & Johnson MedTech has announced the U.S. Food & Drug Administration (FDA) approval of the VARIPULSE Platform ...

During the festive season particularly Diwali in India people can be more susceptible to heart diseases including holiday ...

Johnson & Johnson MedTech has received FDA approval for its device for drug-refractory paroxysmal atrial fibrillation.